WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+3.29%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$4.51B
AUM Growth
+$4.51B
(+20%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
16.11%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74
Top Buys
| 1 |
Gilead Sciences
GILD
|
$99.7M |
| 2 |
Johnson & Johnson
JNJ
|
$79M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$78.4M |
| 4 |
Electronic Arts
EA
|
$60.5M |
| 5 |
Danaher
DHR
|
$59.2M |
Top Sells
| 1 |
Amgen
AMGN
|
$104M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$97.8M |
| 3 |
Medtronic
MDT
|
$68.7M |
| 4 |
Applied Materials
AMAT
|
$67.9M |
| 5 |
NXP Semiconductors
NXPI
|
$61.6M |
Sector Composition
| 1 | Healthcare | 47.83% |
| 2 | Technology | 26.5% |
| 3 | Communication Services | 6.68% |
| 4 | Consumer Discretionary | 4.05% |
| 5 | Financials | 2.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMYQ.U
76
DELISTED
dMY Technology Group, Inc. IV Units, each consisting of one share of Class A common stock and one-fi
DMYQ.U
| $17.2M | 0.38% |
+1,717,205
| New | +$17.2M |
|
77
Acadia Healthcare
ACHC
$2.15B
| $17.2M | 0.38% |
300,389
+247,103
| +464% | +$14.1M |
|
78
Edgewell Personal Care
EPC
$1.1B
| $17M | 0.38% |
428,921
+3,512
| +0.8% | +$139K |
|
79
Alkermes
ALKS
$4.95B
| $16.3M | 0.36% |
871,560
-1,269,809
| -59% | -$23.7M |
|
80
ICU Medical
ICUI
$3.06B
| $16.1M | 0.36% |
78,475
+9,216
| +13% | +$1.89M |
|
81
AbbVie
ABBV
$374B
| $15.3M | 0.34% |
+141,235
| New | +$15.3M |
|
82
HP
HPQ
$26.8B
| $15.2M | 0.34% |
479,467
+314,769
| +191% | +$9.99M |
|
83
Jabil
JBL
$21.8B
| $14.9M | 0.33% |
286,068
+84,653
| +42% | +$4.42M |
|
|
84
Applied Materials
AMAT
$124B
| $14.7M | 0.33% |
110,076
-508,341
| -82% | -$67.9M |
|
|
MTEM
85
DELISTED
Molecular Templates, Inc.
MTEM
| $14.5M | 0.32% |
76,368
+41,857
| +121% | +$7.92M |
|
86
Immunovant
IMVT
$2.91B
| $14.4M | 0.32% |
896,617
+594,714
| +197% | +$9.54M |
|
87
Western Digital
WDC
$29.8B
| $14.2M | 0.32% |
+281,646
| New | +$14.2M |
|
88
Semtech
SMTC
$5.03B
| $14.2M | 0.31% |
205,323
+102,239
| +99% | +$7.05M |
|
89
Hologic
HOLX
$14.7B
| $13.6M | 0.3% |
182,958
-164,766
| -47% | -$12.3M |
|
90
Exelixis
EXEL
$9.95B
| $13.5M | 0.3% |
598,308
+325,508
| +119% | +$7.35M |
|
91
Sana Biotechnology
SANA
$759M
| $13.5M | 0.3% |
+401,994
| New | +$13.5M |
|
92
Atea Pharmaceuticals
AVIR
$275M
| $13.3M | 0.3% |
215,673
-60,410
| -22% | -$3.73M |
|
|
APTO
93
DELISTED
Aptose Biosciences, Inc.
APTO
| $13.3M | 0.29% |
4,930
+2,792
| +131% | +$7.51M |
|
|
SWTX
94
DELISTED
SpringWorks Therapeutics
SWTX
| $12.9M | 0.29% |
175,328
+45,496
| +35% | +$3.35M |
|
|
BHVN
95
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.9M | 0.29% |
+188,256
| New | +$12.9M |
|
|
DOYU
96
DouYu International Holdings
DOYU
$244M
| $12.7M | 0.28% |
121,888
-47,681
| -28% | -$4.96M |
|
97
Encompass Health
EHC
$12.5B
| $12.6M | 0.28% |
193,827
-43,688
| -18% | -$2.85M |
|
98
PTC Therapeutics
PTCT
$4.41B
| $12.4M | 0.27% |
261,534
+141,063
| +117% | +$6.68M |
|
99
Bolt Biotherapeutics
BOLT
$9.29M
| $12.3M | 0.27% |
+18,706
| New | +$12.3M |
|
100
Edgewise Therapeutics
EWTX
$1.54B
| $11.6M | 0.26% |
+357,429
| New | +$11.6M |
|